Shangbin Tang

Shangbin Tang

Auto-generated profile, based on publicly available information

Shangbin Tang

University of California San Diego

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2022 in Journal of the American Pharmacists Association
Verified
Journal Article
Open access
LBLucas A. Berenbrok
Lucas A. Berenbrok
STShangbin Tang
Shangbin Tang
NGNico Gabriel
Nico Gabriel
JGJingchuan Guo
Jingchuan Guo
Nasser ShararehNasser Sharareh
Nasser Sharareh
IHInmaculada Hernandez
Inmaculada Hernandez
Pharmacy accessibility is key for the emerging role of community pharmacists as providers of patient-centered, medication management services in addition to traditional dispensing roles. To quantify population access to community pharmacies across the United States. We obtained addresses for pharmacy locations in the United States from the National Council for Prescription Drug Programs and geocoded each. For a 1% sample of a U.S. synthetic population, we calculated the driving distance to the closest pharmacy using ArcGIS. We estimated the proportion of population living within 1, 2, 5, and 10 miles of a community pharmacy. We quantified the role of chain vs regional franchises or independently owned pharmacies in providing access across degrees of urbanicity. We identified 61,715 pharmacies, including 37,954 (61.5%) chains, 23,521 (38.1%) regional franchises or independently owned pharmacies, and 240 (0.4%) government pharmacies. In large metropolitan areas, 62.8% of the pharmacies were chains; however, in rural areas, 76.5% of pharmacies were franchises or independent pharmacies. Across the overall U.S. population, 48.1% lived within 1 mile of any pharmacy, 73.1% within 2 miles, 88.9% within 5 miles, and 96.5% within 10 miles. Across the United States, 8.3% of counties had at least 50% of residents with a distance greater than 10 miles. These low-access counties were concentrated in Alaska, South Dakota, North Dakota, and Montana. Community pharmacies may serve as accessible locations for patient-centered, medication management services that enhance the health and wellness of communities. Although chain pharmacies represent the majority of pharmacy locations across the country, access to community pharmacies in rural areas predominantly relies on regional franchises and independently owned pharmacies.

28 July 2022 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
IHInmaculada Hernandez
Inmaculada Hernandez
SDSean Dickson
Sean Dickson
STShangbin Tang
Shangbin Tang
NGNico Gabriel
Nico Gabriel
LBLucas A. Berenbrok
Lucas A. Berenbrok
JGJingchuan Guo
Jingchuan Guo
Background: The US Centers for Disease Control and Prevention has repeatedly called for Coronavirus Disease 2019 (COVID-19) vaccine equity. The objective our study was to measure equity in the early distribution of COVID-19 vaccines to healthcare facilities across the US. Specifically, we tested whether the likelihood of a healthcare facility administering COVID-19 vaccines in May 2021 differed by county-level racial composition and degree of urbanicity. Methods and findings: The outcome was whether an eligible vaccination facility actually administered COVID-19 vaccines as of May 2021, and was defined by spatially matching locations of eligible and actual COVID-19 vaccine administration locations. The outcome was regressed against county-level measures for racial/ethnic composition, urbanicity, income, social vulnerability index, COVID-19 mortality, 2020 election results, and availability of nontraditional vaccination locations using generalized estimating equations. Across the US, 61.4% of eligible healthcare facilities and 76.0% of eligible pharmacies provided COVID-19 vaccinations as of May 2021. Facilities in counties with >42.2% non-Hispanic Black population (i.e., > 95th county percentile of Black race composition) were less likely to serve as COVID-19 vaccine administration locations compared to facilities in counties with <12.5% non-Hispanic Black population (i.e., lower than US average), with OR 0.83; 95% CI, 0.70 to 0.98, p = 0.030. Location of a facility in a rural county (OR 0.82; 95% CI, 0.75 to 0.90, p < 0.001, versus metropolitan county) or in a county in the top quintile of COVID-19 mortality (OR 0.83; 95% CI, 0.75 to 0.93, p = 0.001, versus bottom 4 quintiles) was associated with decreased odds of serving as a COVID-19 vaccine administration location. There was a significant interaction of urbanicity and racial/ethnic composition: In metropolitan counties, facilities in counties with >42.2% non-Hispanic Black population (i.e., >95th county percentile of Black race composition) had 32% (95% CI 14% to 47%, p = 0.001) lower odds of serving as COVID administration facility compared to facilities in counties with below US average Black population. This association between Black composition and odds of a facility serving as vaccine administration facility was not observed in rural or suburban counties. In rural counties, facilities in counties with above US average Hispanic population had 26% (95% CI 11% to 38%, p = 0.002) lower odds of serving as vaccine administration facility compared to facilities in counties with below US average Hispanic population. This association between Hispanic ethnicity and odds of a facility serving as vaccine administration facility was not observed in metropolitan or suburban counties. Our analyses did not include nontraditional vaccination sites and are based on data as of May 2021, thus they represent the early distribution of COVID-19 vaccines. Our results based on this cross-sectional analysis may not be generalizable to later phases of the COVID-19 vaccine distribution process. Conclusions: Healthcare facilities in counties with higher Black composition, in rural areas, and in hardest-hit communities were less likely to serve as COVID-19 vaccine administration locations in May 2021. The lower uptake of COVID-19 vaccinations among minority populations and rural areas has been attributed to vaccine hesitancy; however, decreased access to vaccination sites may be an additional overlooked barrier.

23 May 2024 in Journal of the American Pharmacists Association
Verified
Journal Article
Closed access
GAGiovanni E Appolon
Giovanni E Appolon
STShangbin Tang
Shangbin Tang
NGNico Gabriel
Nico Gabriel
JMJasmine Morales
Jasmine Morales
LBLucas A. Berenbrok
Lucas A. Berenbrok
IHInmaculada Hernandez
Inmaculada Hernandez

18 July 2025 in Journal of the American Pharmacists Association
Verified
Journal Article
Open access
Nasser ShararehNasser Sharareh
Nasser Sharareh
STShangbin Tang
Shangbin Tang
ABAdam Bress
Adam Bress
WMWalter S. Mathis
Walter S. Mathis
LBLucas A. Berenbrok
Lucas A. Berenbrok
IHInmaculada Hernandez
Inmaculada Hernandez
Previous analyses measuring geographic access to community pharmacies (pharmacy access) have relied solely on driving distance or time, without considering other modes of transportation such as walking and public transportation. This omission represents an important limitation, particularly in metropolitan areas where other transportation modes are regularly used, which potentially can lead to the underestimation of inequities in pharmacy access. To investigate whether measuring pharmacy access based on driving underestimates inequities in access, given the fact that not everyone has access to a vehicle. We used geographic information system analysis to measure pharmacy access. We selected the top 10 metropolitan and micropolitan statistical areas with the largest population in the U.S. because of the feasibility and availability of different transportation modes in those areas. We found that across the top 10 populated U.S. areas and based on a 20-minute travel time, pharmacy access will be overestimated for approximately 702,708 and 2,430,764 individuals if we consider driving as the transportation mode instead of walking and public transportation, respectively. Results suggest that measures of pharmacy access derived solely from driving time will underestimate inequities in pharmacy access, specifically in areas with a low rate of private vehicle ownership.

24 June 2026
Verified
Journal Article
Open access
RKRichard Kronick
Richard Kronick
LJLogan Johnson
Logan Johnson
RKRamona Krauss
Ramona Krauss
STShangbin Tang
Shangbin Tang
DWDaniel Waldo
Daniel Waldo
Prior studies show that beneficiaries with relatively high health needs are more likely to disenroll from Medicare Advantage (MA) and return to Traditional Medicare (TM). However, the financial implications for MA plans of selective disenrollment have not been quantified. We calculated annual disenrollment rates from MA to TM, and compared TM spending in months 1-12 and 13-24 following disenrollment with the expected capitation payments that MA plans would have received. For 2019 disenrollees, TM spending in the first 12 months following disenrollment averaged 30% higher than the expected MA capitation. However, disenrollment was relatively rare—1.7% of MA members in 2019, much lower than the 4.3% in 2007, and declining further to 1.2% in 2022. Because disenrollment is rare, its effect on plan finances is limited, increasing spending on MA by approximately 0.6%. Although the effect of selective disenrollment on plan finances is limited, the consistent direction and magnitude of selection suggest that a measured policy response is warranted.

4 August 2026 in Journal of the American Heart Association
Verified
Journal Article
Open access
LYLanting Yang
Lanting Yang
NGNico Gabriel
Nico Gabriel
STShangbin Tang
Shangbin Tang
LCLauren Cater
Lauren Cater
Hayley BlackburnHayley Blackburn
Hayley Blackburn
IHInmaculada Hernandez
Inmaculada Hernandez
Background: Residents of western US states face elevated fine particulate matter (PM 2.5 ) exposure from increasingly frequent and intense wildfires, raising concerns about cardiovascular risk. Whether short‐term PM 2.5 exposure increases odds of hospitalization or emergency care in patients with established atrial fibrillation (AF) remains unclear. Methods: Using 2021 Medicare data, we identified patients with established AF residing in western US states. Zip code–level daily PM 2.5 was estimated using a 1 km 2 geospatial model; high PM 2.5 was defined as ≥9.0 μg/m 3 . Odds ratios (ORs) for all‐cause and cardiovascular disease hospitalization and emergency department visits were estimated using conditional logistic regression at lag 0, 1, and 3 days, adjusting for extreme heat and public holidays. Results: The final cohort included 26 158 patients (mean age 79 ± 9.0 years) with established AF. Exposure to high levels of PM 2.5 was associated with 10% (95% CI, 1%–20%) increased odds of hospitalizations for cardiovascular disease. Specifically, high PM 2.5 was associated with 24% (95% CI, 3%–48%) increased odds of hospitalization and 34% (95% CI, 6%–70%) higher odds of emergency department visits for all AF‐related diagnoses. We did not observe significant interaction effects between PM 2.5 and extreme heat on the risk of hospitalization or emergency department visits for cardiovascular disease or AF. Conclusion: On days with elevated PM 2.5 levels, patients with AF were associated with higher odds of AF‐related or cardiovascular hospitalizations and emergency department visits, highlighting the need for targeted prevention strategies to protect vulnerable populations from the adverse effects of air pollution.